Ordinary Adjustment | Solactive China Healthcare Disruption Index | Effective Date 2nd June 2025
Solactive China Healthcare Disruption Index:
In the ordinary adjustment, the following composition was implemented effective open 2nd June 2025:
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 8.00% |
SINO BIOPHARMACEUTICAL LTD ORD | 8.00% |
INNOVENT BIOLOGICS INC | 8.00% |
WUXI BIOLOGICS CAYMAN INC | 8.00% |
WUXI APPTEC CO LTD | 8.00% |
HANSOH PHARMACEUTICAL GROUP CO | 8.00% |
AKESO INC | 8.00% |
CSPC PHARMACEUTICAL GROUP LTD | 7.62% |
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 7.07% |
SKB BIO-B ORD H | 5.66% |
LIVZON PHARMACEUTICAL GROUP INC | 3.50% |
CHINA RESOURCES PHARMACEUTICAL | 3.49% |
GRAND PHARMACEUTICAL GROUP LTD | 3.36% |
SHANGHAI JUNSHI BIOSCIENCES CO LTD | 3.06% |
GENSCRIPT BIOTECH CORP | 2.49% |
SHANGHAI MICROPORT MEDBOT GR | 1.77% |
YICHANG HEC CHANGJIANG PHA-H | 0.97% |
SHANGHAI PHARMACEUTICALS HOLDING CO LTD-H | 0.50% |
PHARMARON BEIJING CO LTD-H | 0.50% |
REMEGEN CO LTD-H | 0.43% |
ZAI LAB LTD | 0.40% |
SIMCERE PHARMACEUTICAL GROUP | 0.34% |
CHINA MEDICAL SYSTEM HOLDINGS LTD | 0.32% |
HUTCHMED CHINA LTD | 0.29% |
QUANTUMPHARM INC | 0.27% |
EVEREST MEDICINES LTD | 0.23% |
KEYMED BIOSCIENCES INC | 0.18% |
KANGJI MEDICAL HOLDINGS LTD | 0.15% |
MEDLIVE TECHNOLOGY CO LTD | 0.14% |
TYK MEDICINES-B ORD H | 0.14% |
HBM HOLDINGS LTD | 0.12% |
LEPU BIOPHARMA CO LTD-H | 0.11% |
LUYE PHARMA GROUP LTD | 0.11% |
SHANGHAI FUDAN-ZHANGJIANG BIO- | 0.11% |
SHANGHAI HENLIUS BIOTECH INC | 0.10% |
ALPHAMAB ONCOLOGY | 0.10% |
SIHUAN PHARMACEUTICAL HLDGS GRP ORD | 0.10% |
ABBISKO CAYMAN LTD | 0.09% |
ASCLETIS PHARMA INC | 0.08% |
SHANDONG BOAN BIOTECHNOLOGY CO LTD | 0.08% |
CSTONE PHARMACEUTICALS | 0.06% |
JACOBIO PHARMACEUTICALS GROUP CO LTD | 0.05% |